Drug Design
CloudPharm uses cloud-based drug design protocols for rigorous virtual screening, hit to lead optimization, molecular modeling, docking etc.
On demand R&D solutions
Cloupharm is currently building an ad-hoc network of collaborators from industry and academia providing solutions for R&D regarding in vitro, in vivo testing and wet lab services according to your needs.
Active ingredient repositioning
Cloudpharm is developing an in house platform that will be able to investigate whether known drug molecules could interact with other protein targets, using computational tools and protein 3D information.
Our vision
Cloudpharm aspires to support research in an international dimension, to bring new ideas in the market, to create value for its customers and to build an ideal environment for its people.
- De novo design of potential bioactive molecules
- Lead optimization of active chemical series
- Target assessment of proteins with pharmaceutical interest
- Molecular dynamics of biological systems
- Ligand-based and structure-based pharmacophore screening
- Absorption, Distribution, Metabolism and Excretion profiling
- In silico predictive toxicity of compounds
- Docking of compounds to target proteins
- Screening of natural products for potential pharmaceutical application
Why Choose Us ?
Cloudpharm has developed several protocols, devoted to database mining and compound selection to maximize success rates after drug screening. We have established collaborations with Universities and research institutes on long term drug development projects, aiming to develop anti-cancer, anti-inflammatory and cardiovascular agents.
Lancom, a cloud service provider in Greece, provides Cloudpharm autonomous virtual servers, on its proprietary Data Center. The dedicated servers, are used for all the computational tasks, docking, pharmacophore modeling, virtual screening etc. and constantly ensure for the proper management and allocation of the shared resources of the systems, achieving their full potential on the basis of the specific needs of Cloudpharm.
"If you break a piece of matter in half, and then break it in half again, how many breaks will you have to make before you can break it no further?"
Democritus, 460 B.C.,
"I rather expect that we shall some day find, for what we now call atoms, a mathematico-mechanical explanation, which will render an account of atomic weight, of atomicity, and of numerous other properties of the so-called atoms."
August Kekulé, 1867,
"We must be clear that when it comes to atoms, language can be used only as in poetry. The poet, too, is not nearly so concerned with describing facts as with creating images and establishing mental connections. "
Niels Bohr, 1920,
"Who then can calculate the path of the molecule? how do we know that the creations of worlds are not determined by the fall of grains of sand?"
Victor Hugo, 1862,
"The separate atoms of a molecule are not connected all with all, or all with one, but, on the contrary, each one is connected only with one or with a few neighbouring atoms, just as in a chain link is connected with link."
August Kekulé, 1878,
"For us, an atom shall be a small, spherical, homogeneous body or an essentially indivisible, material point, whereas a molecule shall be a separate group of atoms in any number and of any nature."